Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | JNJ-80948543 |
| Trade Name | |
| Synonyms | JNJ 80948543|JNJ80948543 |
| Drug Descriptions |
JNJ-80948543 is an antibody that targets an undisclosed tumor-associated antigen (TAA) and the T-cell antigen CD3, potentially resulting in activation of cytotoxic T-lymphocytes (CTLs) and tumor cell killing (NCI Drug Dictionary). |
| DrugClasses | CD3 Antibody 119 |
| CAS Registry Number | NA |
| NCIT ID | C188792 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| JNJ-75348780 + JNJ-80948543 | JNJ-75348780 JNJ-80948543 | 0 | 1 |
| JNJ-80948543 | JNJ-80948543 | 0 | 1 |
| JNJ-80948543 + JNJ-87801493 | JNJ-80948543 JNJ-87801493 | 0 | 1 |